Novartis CEO: Expect continued growth in 2023 Published 2023-02-01 Download video MP4 360p Recommendations 04:17 Novartis CEO: We expect our six key drugs to grow ahead of analyst expectations 09:08 Vas Narasimhan at the 2019 One Young World Summit 25:17 Novartis CEO Vas Narasimhan: How to be a boss in an “unbossed” company 02:14 Amrita Sen talks oil demand outlook and the path for OPEC+ production cuts 04:20 Investors should stick to the barbell approach, says Wolfe Research's Chris Senyek 06:23 Sandoz will be a long-term stable business if it can get its cost structure right, Novasecta says 03:25 Reimagine what you could do at Novartis 20:01 Канада: стратегічний підхід до імміграції I Ціна держави 11:44 Talking culture transformation with Vas Narasimhan and Adam Grant 03:43 Novartis CEO Vas Narasimhan on the latest research on a breast cancer drug 24:05 The David Rubenstein Show: Satya Nadella 23:37 Reimagining Medicine with Data & Digital | Novartis CEO at #VivaTech19 24:36 70 Years Of History Lead To This... 08:39 How an Obscure Tax Break Became a ‘Gold Rush’ | WSJ 14:05 House of Ken Griffin – The Story of Citadel | A Documentary 07:25 Novartis CEO: Setting Up Sandoz for Next Wave of Growth 11:50 Novartis ‘focusing on high-end, innovative medicines,’ CEO says 09:10 Why So Many CEOs are from India Similar videos 04:16 Novartis CEO Vas Narasimhan: Our medicines are starting to take market share and deliver on promises 03:29 Novartis generated $40 billion in innovative medicine sales, says CEO 04:17 Novartis transformation into a pure-play Innovative Medicines company 07:01 Novartis CEO: Nations pulling back on health care spending ‘has long-term consequences' 00:54 Novartis as a focused innovative medicines company 00:52 Novartis – Who We Are 04:56 'We have reached an endemic environment with Covid,' says Novartis CEO 01:10 Novartis commitment to ESG 00:54 What does belonging mean to you? Steve’s story 03:34 Expect concrete decision before the end of the year on Sandoz, says Novartis CEO 05:48 Next Generation Scientist 2022 00:54 Novartis 2022 Key Statistics 1:14:00 Novartis $NVS Q1 2023 Earnings Call 00:46 Novartis areas of focus More results